Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Structural basis for the design of selective phosphodiesterase 4B inhibitors
David Fox, Alex B. Burgin, Mark E. Gurney
Cellular Signalling (2013) Vol. 26, Iss. 3, pp. 657-663
Open Access | Times Cited: 86

Showing 26-50 of 86 citing articles:

Mapping the Ligand Binding Landscape
Alex Dickson
Biophysical Journal (2018) Vol. 115, Iss. 9, pp. 1707-1719
Open Access | Times Cited: 42
Phosphodiesterase‑4 inhibitors: a review of current developments (2013–2021)
Zhihao Liu, Mingjian Liu, Zhenqing Cao, et al.
Expert Opinion on Therapeutic Patents (2022) Vol. 32, Iss. 3, pp. 261-278
Closed Access | Times Cited: 21
Cyclic nucleotide phosphodiesterases as drug targets
Michy P. Kelly, Viacheslav O. Nikolaev, Leila Gobejishvili, et al.
Pharmacological Reviews (2025) Vol. 77, Iss. 3, pp. 100042-100042
Open Access
Role of PDE4 Family in Cardiomyocyte Physiology and Heart Failure
Ivan Sherstnev, Aleksandra Judina, Giovanni Battista Luciani, et al.
Cells (2025) Vol. 14, Iss. 6, pp. 460-460
Open Access
New insights into selective PDE4D inhibitors: 3-(Cyclopentyloxy)-4-methoxybenzaldehyde O-(2-(2,6-dimethylmorpholino)-2-oxoethyl) oxime (GEBR-7b) structural development and promising activities to restore memory impairment
Chiara Brullo, Roberta Ricciarelli, Jos Prickaerts, et al.
European Journal of Medicinal Chemistry (2016) Vol. 124, pp. 82-102
Closed Access | Times Cited: 35
InCl3 mediated heteroarylation of indoles and their derivatization via C H activation strategy: Discovery of 2-(1H-indol-3-yl)-quinoxaline derivatives as a new class of PDE4B selective inhibitors for arthritis and/or multiple sclerosis
Rajnikanth Sunke, Ramudu Bankala, B. Thirupataiah, et al.
European Journal of Medicinal Chemistry (2019) Vol. 174, pp. 198-215
Closed Access | Times Cited: 34
Therapeutic benefits of phosphodiesterase 4B inhibition after traumatic brain injury
Nicole M. Wilson, Mark E. Gurney, W. Dalton Dietrich, et al.
PLoS ONE (2017) Vol. 12, Iss. 5, pp. e0178013-e0178013
Open Access | Times Cited: 33
The PDE4 cAMP-Specific Phosphodiesterases: Targets for Drugs with Antidepressant and Memory-Enhancing Action
Graeme B. Bolger
Advances in neurobiology (2017), pp. 63-102
Closed Access | Times Cited: 33
Discovery of N-Alkyl Catecholamides as Selective Phosphodiesterase-4 Inhibitors with Anti-neuroinflammation Potential Exhibiting Antidepressant-like Effects at Non-emetic Doses
Zhong‐Zhen Zhou, Yufang Cheng, Zhengqiang Zou, et al.
ACS Chemical Neuroscience (2016) Vol. 8, Iss. 1, pp. 135-146
Closed Access | Times Cited: 32
Identification of a multifunctional docking site on the catalytic unit of phosphodiesterase-4 (PDE4) that is utilised by multiple interaction partners
Kirsty F. Houslay, Christian Frank, Ruth MacLeod, et al.
Biochemical Journal (2016) Vol. 474, Iss. 4, pp. 597-609
Open Access | Times Cited: 32
Phosphodiesterase-4 Inhibitors for Non-COPD Respiratory Diseases
Theerasuk Kawamatawong
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 25
PDE Inhibitors for the Treatment of Schizophrenia
Gretchen L. Snyder, Kimberly E. Vanover
Advances in neurobiology (2017), pp. 385-409
Closed Access | Times Cited: 31
Apremilast-induced increases in acute ethanol intoxication and decreases in ethanol drinking in mice involve PKA phosphorylation of GABAA β3 subunits
Yuri A. Blednov, Adriana Da Costa, Sonia Mason, et al.
Neuropharmacology (2022) Vol. 220, pp. 109255-109255
Open Access | Times Cited: 14
Selective PDE4B and PDE4D inhibitors produce distinct behavioral responses to ethanol and GABAergic drugs in mice
Yuri A. Blednov, Adriana Da Costa, Sonia Mason, et al.
Neuropharmacology (2023) Vol. 231, pp. 109508-109508
Open Access | Times Cited: 8
A novel phosphodiesterase inhibitor for the treatment of chronic liver injury and metabolic diseases
Dalton W. Staller, Sanjali S. Panigrahi, Yahani P. Jayasinghe, et al.
Hepatology (2024)
Closed Access | Times Cited: 2
Biphenyl Pyridazinone Derivatives as Inhaled PDE4 Inhibitors: Structural Biology and Structure–Activity Relationships
Jordi Gràcia, María Antonia Buil, Jordi Castro, et al.
Journal of Medicinal Chemistry (2016) Vol. 59, Iss. 23, pp. 10479-10497
Closed Access | Times Cited: 21
Synthesis of 11,12-dihydro benzo[c]phenanthridines via a Pd-catalyzed unusual construction of isocoumarin ring/FeCl3-mediated intramolecular arene-allyl cyclization: First identification of a benzo[c]phenanthridine based PDE4 inhibitor
B. Thirupataiah, Gangireddy Sujeevan Reddy, Shailendra S. Ghule, et al.
Bioorganic Chemistry (2020) Vol. 97, pp. 103691-103691
Closed Access | Times Cited: 19
Identification of a Selective PDE4B Inhibitor From Bryophyllum pinnatum by Target Fishing Study and In Vitro Evaluation of Quercetin 3-O-α-L-Arabinopyranosyl-(1→2)-O-α-L-Rhamnopyranoside
Estela Mariana Guimarães Lourenço, Júlia Morais Fernandes, Vinícius F. Carvalho, et al.
Frontiers in Pharmacology (2020) Vol. 10
Open Access | Times Cited: 18
Docking based screening and molecular dynamics simulations to identify potential selective PDE4B inhibitor
Mayasah Al‐Nema, Anand Gaurav, Vannajan Sanghiran Lee
Heliyon (2020) Vol. 6, Iss. 9, pp. e04856-e04856
Open Access | Times Cited: 18
Selective Inhibition of PDE4B Reduces Binge Drinking in Two C57BL/6 Substrains
C. Leonardo Jimenez Chavez, Camron D. Bryant, Melissa A. Munn‐Chernoff, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 11, pp. 5443-5443
Open Access | Times Cited: 16
Targeting phosphodiesterase 4 as a therapeutic strategy for cognitive improvement
Xuemei Wei, Guoqi Yu, Hualiang Shen, et al.
Bioorganic Chemistry (2022) Vol. 130, pp. 106278-106278
Closed Access | Times Cited: 11
New insights into PDE4B inhibitor selectivity: CoMFA analyses and molecular docking studies
Sara Guariento, Olga Bruno, Paola Fossa, et al.
Molecular Diversity (2015) Vol. 20, Iss. 1, pp. 77-92
Closed Access | Times Cited: 20
Synthesis, Biological Evaluation, and Molecular Modeling of New 3-(Cyclopentyloxy)-4-methoxybenzaldehyde O-(2-(2,6-Dimethylmorpholino)-2-oxoethyl) Oxime (GEBR-7b) Related Phosphodiesterase 4D (PDE4D) Inhibitors
Chiara Brullo, Matteo Massa, Massimo Rocca, et al.
Journal of Medicinal Chemistry (2014) Vol. 57, Iss. 16, pp. 7061-7072
Closed Access | Times Cited: 19
PDE4B Induces Epithelial-to-Mesenchymal Transition in Bladder Cancer Cells and Is Transcriptionally Suppressed by CBX7
Zhengnan Huang, Jiakuan Liu, Jiale Yang, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 15
4-Amino-7,8-dihydro-1,6-naphthyridin-5(6H)-ones as Inhaled Phosphodiesterase Type 4 (PDE4) Inhibitors: Structural Biology and Structure–Activity Relationships
Richard S. Roberts, Sara Sevilla, Manel Ferrer, et al.
Journal of Medicinal Chemistry (2018) Vol. 61, Iss. 6, pp. 2472-2489
Closed Access | Times Cited: 18

Scroll to top